Malignant Arrhythmic Mitral Valve Prolapse: A Continuum of Clinical Challenges from Diagnosis to Risk Stratification and Patient Management

Yedidya, Idit; van Wijngaarden, Aniek L.; Ajmone Marsan, Nina

doi:10.3390/jcdd8010002

Open AccessCase Report

Malignant Arrhythmic Mitral Valve Prolapse: A Continuum of Clinical Challenges from Diagnosis to Risk Stratification and Patient Management

by

Idit Yedidya

^1,2

,

Aniek L. van Wijngaarden

¹

and

Nina Ajmone Marsan

^1,*

¹

Department of Cardiology, Leiden University Medical Center, Leiden, 2300RC Zuid-Holland, The Netherlands

²

Department of Cardiology, Rabin Medical Center, Petah-Tikva 49372, Israel

^*

Author to whom correspondence should be addressed.

J. Cardiovasc. Dev. Dis. 2021, 8(1), 2; https://doi.org/10.3390/jcdd8010002

Submission received: 30 October 2020 / Revised: 15 December 2020 / Accepted: 24 December 2020 / Published: 29 December 2020

(This article belongs to the Special Issue Mitral Valve Development and Disease)

Download

Browse Figures

Versions Notes

Abstract

Mitral valve prolapse (MVP) is a common valvular disease, which may remain a benign condition for a long period of time. However, some patients experience malignant ventricular arrhythmias and sudden cardiac death (SCD). It is still largely unknown how to risk-stratify these patients, and no specific recommendations have been proposed to help the clinical decision-making. We present the case of a young man whose first clinical presentation was an out-of-hospital cardiac arrest and was subsequently diagnosed with MVP. We highlighted the possible risk factors for SCD and the challenges in the clinical management of these patients.

Keywords: mitral valve prolapse; sudden cardiac death; risk factors

Share and Cite

MDPI and ACS Style

Yedidya, I.; van Wijngaarden, A.L.; Ajmone Marsan, N. Malignant Arrhythmic Mitral Valve Prolapse: A Continuum of Clinical Challenges from Diagnosis to Risk Stratification and Patient Management. J. Cardiovasc. Dev. Dis. 2021, 8, 2. https://doi.org/10.3390/jcdd8010002

AMA Style

Yedidya I, van Wijngaarden AL, Ajmone Marsan N. Malignant Arrhythmic Mitral Valve Prolapse: A Continuum of Clinical Challenges from Diagnosis to Risk Stratification and Patient Management. Journal of Cardiovascular Development and Disease. 2021; 8(1):2. https://doi.org/10.3390/jcdd8010002

Chicago/Turabian Style

Yedidya, Idit, Aniek L. van Wijngaarden, and Nina Ajmone Marsan. 2021. "Malignant Arrhythmic Mitral Valve Prolapse: A Continuum of Clinical Challenges from Diagnosis to Risk Stratification and Patient Management" Journal of Cardiovascular Development and Disease 8, no. 1: 2. https://doi.org/10.3390/jcdd8010002

APA Style

Yedidya, I., van Wijngaarden, A. L., & Ajmone Marsan, N. (2021). Malignant Arrhythmic Mitral Valve Prolapse: A Continuum of Clinical Challenges from Diagnosis to Risk Stratification and Patient Management. Journal of Cardiovascular Development and Disease, 8(1), 2. https://doi.org/10.3390/jcdd8010002

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Menu

Malignant Arrhythmic Mitral Valve Prolapse: A Continuum of Clinical Challenges from Diagnosis to Risk Stratification and Patient Management

Abstract

Share and Cite

Article Metrics

Article Access Statistics

Further Information

Guidelines

MDPI Initiatives

Follow MDPI